Cadre Beats Again, Raises 2026 Guidance and Authorizes $100M Buyback
CDRE sits 28% above its 52-week low of $24.07.
Summary
Cadre posted Q3 net sales of $202.9 million, up 30% from $155.9 million a year ago, with net income up 46% to $16.0 million ($0.37 per diluted share) and Adjusted EBITDA of $41.1 million at a 20.2% margin, up 110 basis points. Management credited double-digit organic growth plus acquisitions, and said demand was better than expected. The company raised full-year 2026 guidance to net sales of $756-$769 million and Adjusted EBITDA of $140-$144 million, and the board authorized a new $100 million share repurchase program. Balance sheet leverage rose with the acquisition spend: net debt climbed to $305.6 million from $184.4 million at year-end 2025. The buyback is notable given CEO Warren Kanders' repeated Form 144 sales and the September pledge of 2 million additional shares as margin collateral. Q3 results call is November 5 at 10:00 a.m. EST.
At the time of this announcement, CDRE was trading at $30.84 on NYSE in the Manufacturing sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $24.07 to $48.76. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.